Sonia Maria Poli

Direktor/Vorstandsmitglied bei DIMERIX LIMITED

Vermögen: 85 381 $ am 30.04.2024

59 Jahre

Health Technology

Consumer Services

Distribution Services

Aktive Positionen von Sonia Maria Poli

Unternehmen	Position	Beginn	Ende
DIMERIX LIMITED	Direktor/Vorstandsmitglied	03.07.2015	-
DIMERIX LIMITED	Independent Dir/Board Member	03.07.2015	-
AC IMMUNE SA	Corporate Officer/Principal	01.09.2017	-
Dimerix Bioscience Pty Ltd. Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia.	Direktor/Vorstandsmitglied	01.05.2014	-
	Vorstandsvorsitzender	01.05.2014	-
Minoryx Therapeutics SL Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain.	Technik-/Wissenschafts-/F&E-Leiter	01.08.2019	-

Unternehmen	Position	Beginn	Ende
ADDEX THERAPEUTICS LTD	Technik-/Wissenschafts-/F&E-Leiter	-	18.09.2017
F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.	Corporate Officer/Principal	01.01.2004	01.01.2004

University of Milan

Doctorate Degree

International

Operativ

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	2
Director/Board Member	2

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
ADDEX THERAPEUTICS LTD	Health Technology
DIMERIX LIMITED	Health Technology
AC IMMUNE SA	Health Technology

Private Unternehmen	3
F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.	Health Technology
Dimerix Bioscience Pty Ltd. Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia.	Distribution Services
Minoryx Therapeutics SL Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain.	Health Technology